A drug that can answer for itself, and prove every word.
Ask the Med turns a medicine's approved knowledge into something a person can simply talk to. Every answer cites the exact source document, refuses to guess when the label is silent, and carries a cryptographic signature anyone can verify. It is built for the one thing regulated medical information cannot compromise on: trust you can inspect.
Three guarantees on every answer
A general chatbot will confidently fill a gap it cannot support. In medical information, that is not a quality issue, it is a compliance failure. Ask the Med is built so a wrong or unsupported answer cannot quietly ship.
Grounded in source
Answers are drawn only from the medicine's approved documents, and every claim names the exact source it came from, down to the section.
Honest abstention
When the labeling does not address a question, it says so plainly instead of inventing an answer. Knowing what it does not know is a feature, not a gap.
Signed and verifiable
Each answer is cryptographically signed. An auditor can confirm the exact question, response, and time using only a public key, trusting nothing about the system that produced it.
From source document to inspection-ready answer
The mechanics stay behind the curtain. What matters is the chain of custody, and that it holds end to end.
The knowledge goes into protected memory
A medicine's prescribing information, standard response documents, and congress materials are loaded into an isolated, access-controlled memory. Each document is sealed with a cryptographic fingerprint, so any later change is detectable.
A person asks in plain language
An HCP, an MSL, or a contact-center specialist asks a question the way they would ask a colleague. No query language, no training the user.
The answer is assembled from cited sources
The system retrieves the supporting passages, drafts the answer only from them, attaches the source-document IDs, and abstains where nothing supports a claim.
Every answer leaves a verifiable record
The question, the response, and the moment it was given are bound into a signed receipt. Months later, an inspector can confirm exactly what was said and that it has not been altered.
The problem this was built to end
Teams that tried a first-generation medical-information chatbot tend to hit the same wall. The pain is not the model, it is everything around it.
The chatbot treadmill
- Content pooled from scattered platforms, converted and re-converted before it can be used
- Constant retraining and refinement after every label or document change
- Staff pulled in to resolve the moments the bot could not answer
- No trail proving why an answer was given, or that it matched the source
What changes here
- One governed source of truth per medicine, updated in one place
- Add or revise a document and the answers follow, no retraining cycle
- The system abstains cleanly instead of handing off a silent failure
- Every answer carries its own provenance and a signature you can check
In early 2026 regulators signaled that AI used in drug safety must be explainable, traceable, and inspection-ready, held to the same bar as any other regulated system. Grounded answers, source provenance, and a tamper-evident record are exactly that bar. This is built toward it from the first line.
One substrate, many clients, none of them touching
The same approach that lets one medicine answer for itself scales to a portfolio of client products, offered as a differentiated, provenance-native service rather than a generic bot.
- Per-client isolation. Each client's knowledge lives in its own walled namespace. One client's content can never surface in another client's answer, and that separation is enforced at the data layer, not by convention.
- White-label by configuration. New products and new clients are onboarded by loading documents, not by rebuilding the system. The substrate is the same; the corpus is what changes.
- Fits the existing workflows. Medical information response, promotional and medical review, and pharmacovigilance intake all benefit from the same grounded, cited, signed foundation.
- Inspection-readiness as the product. The differentiator is not that it answers, it is that every answer can withstand scrutiny. That is the part a services firm cannot easily build and a heavy enterprise platform bolts on awkwardly.
Honest scope
This is a demonstration on Zelavantinib (VANTEXA), a fictional medicine created for this purpose. It carries no patient data and no real regulated content, which is exactly why the demo can run in the open: a base model has never seen this drug, so any correct sourced answer provably comes from the protected memory, not the model.
The architecture is built toward the inspection-readiness regulators are asking for. It is not presented as a validated system, and makes no HIPAA, 21 CFR Part 11, or GxP compliance claim. Formal computer-system validation and a signed agreement are the documented steps before any real, regulated deployment. This page explains the concept; it does not describe the underlying infrastructure.